Hilde Windels is an experienced business development consultant currently serving at DeuterOncology NV and Microphyt, while also holding multiple board positions including at Gimv, MDxHealth, Celyad, and PHAXIAM Therapeutics. Windels previously held the role of CEO at MyCartis and Antelope Dx, and served as a committee member at VARIO. In addition, Windels was a board member at VIB. Educational background includes a Master's degree in Commercial Engineering from KU Leuven and a Latin-mathematics degree from Onze Lieve Vrouw Vlaanderen, Kortrijk.
Sign up to view 0 direct reports
Get started